BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2816118
Number of visits today
1284
Number of downloads
2065786
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Becirovic E. Maybe you can turn me on: CRISPRa-based strategies for therapeutic applications. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04175-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Michurina S, Stafeev I, Boldyreva M, Truong VA, Ratner E, Menshikov M, Hu YC, Parfyonova Y. Transplantation of Adipose-Tissue-Engineered Constructs with CRISPR-Mediated UCP1 Activation. Int J Mol Sci 2023;24. [PMID: 36835254 DOI: 10.3390/ijms24043844] [Reference Citation Analysis]
2 Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X, He X, Liu M, Li PF, Yu T. CRISPR/Cas9 therapeutics: progress and prospects. Signal Transduct Target Ther 2023;8:36. [PMID: 36646687 DOI: 10.1038/s41392-023-01309-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sun T, Xu W, Tu B, Wang T, Liu J, Liu K, Luan Y. Engineered Adipose-Derived Stem Cells Overexpressing RXFP1 via CRISPR Activation Ameliorate Erectile Dysfunction in Diabetic Rats. Antioxidants (Basel) 2023;12. [PMID: 36671033 DOI: 10.3390/antiox12010171] [Reference Citation Analysis]
4 Chang HC, Lee YJ, Javed S, Haque M, Chang YT, Lin YC, Oram C, Huang WH. rAAV-CRISPRa therapy corrects Rai1 haploinsufficiency and rescues selective disease features in Smith-Magenis syndrome mice. J Biol Chem 2023;299:102728. [PMID: 36410433 DOI: 10.1016/j.jbc.2022.102728] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345